Apellis Pharmaceuticals
APLS
$49.86
Share price
4.03%
Change (1 day)
-41.12%
Change (1 year)
Categories
Apellis Pharmaceuticals (APLS) - Total debt
Total debt on the balance sheet as of December 2023 : $0.11 B
According to Apellis Pharmaceuticals's latest financial reports the company's total debt is $0.11 B. A company’s total debt is the sum of all current and non-current debts.
Apellis Pharmaceuticals - Total debt on balance sheet (from 2017 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.11 B | -1.58% |
| 2022-12-31 | $0.11 B | -46.38% |
| 2021-12-31 | $0.21 B | -44.35% |
| 2020-12-31 | $0.37 B | 140.54% |
| 2019-12-31 | $0.15 B | 480.65% |
| 2018-12-31 | $27.04 M | 2.48% |
| 2017-12-31 | $26.39 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $2.75 M | -97.52% | 🇺🇸 USA |